Strategies to reduce illicit trade of regular nicotine tobacco products after introduction of a low-nicotine tobacco product standard

Kurt M. Ribisl, Dorothy K. Hatsukami, Jidong Huang, Rebecca S. Williams, Eric C. Donny

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


The US Food and Drug Administration is considering mandating a substantial reduction in the nicotine level of cigarettes and possibly other combusted tobacco products to render them minimially addictive. This would likely result in several public health benefits, including increased cessation, decreased progression to dependence, and reduced consumption of combusted tobacco products. However, findings from clinical trials of reduced-nicotine cigarettes suggest that many smokers consuming low nicotine-content cigarettes sought out regular nicotine-content cigarettes, even when they were asked to only smoke free low-nicotine cigarettes. If this policy were implemented without ensuring that cessation treatments and appealing alternative products (e.g., e-cigarettes) were readily available, some consumers would be likely to seek banned regular nicotine-content combusted tobacco products from illicit sources: retail, online, and individuals. Left unchecked, this illicit market could undermine the public health benefits of the policy. We describe supply and demand factors in an illicit market. Informed by the literature on controlling Internet tobacco sales and reducing illicit trade in low-cost cigarettes when there are price differentials, we recommend tracking and tracing products and greater surveillance and enforcement efforts to minimize illicit trade in normal nicotine products under a low-nicotine tobacco product standard.

Original languageEnglish (US)
Pages (from-to)1007-1014
Number of pages8
JournalAmerican journal of public health
Issue number7
StatePublished - Jul 2019

Bibliographical note

Funding Information:
Research reported in this publication was supported by the National Cancer Institute (NCI) and the Food and Drug Administration (FDA) Center for Tobacco Products (grant P50CA180907), the National Institute of Drug Abuse (NIDA; grant U54 DA031659), the NIDA and the FDA (grant P50DA036128), and the NCI (grant R01CA169189).

Publisher Copyright:
© 2019 American Public Health Association Inc.. All rights reserved.


Dive into the research topics of 'Strategies to reduce illicit trade of regular nicotine tobacco products after introduction of a low-nicotine tobacco product standard'. Together they form a unique fingerprint.

Cite this